GB9710523D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9710523D0 GB9710523D0 GBGB9710523.3A GB9710523A GB9710523D0 GB 9710523 D0 GB9710523 D0 GB 9710523D0 GB 9710523 A GB9710523 A GB 9710523A GB 9710523 D0 GB9710523 D0 GB 9710523D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710523.3A GB9710523D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
CA002290475A CA2290475A1 (en) | 1997-05-23 | 1998-05-13 | Indoline derivatives as 5ht2c receptor antagonists |
PCT/EP1998/002992 WO1998052943A1 (en) | 1997-05-23 | 1998-05-13 | Indoline derivatives as 5ht2c receptor antagonists |
EP98925626A EP0984956A1 (en) | 1997-05-23 | 1998-05-13 | Indoline derivatives as 5ht2c receptor antagonists |
JP54996098A JP2001526674A (en) | 1997-05-23 | 1998-05-13 | Indoline derivatives as 5HT2C receptor antagonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710523.3A GB9710523D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9710523D0 true GB9710523D0 (en) | 1997-07-16 |
Family
ID=10812842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9710523.3A Pending GB9710523D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0984956A1 (en) |
JP (1) | JP2001526674A (en) |
CA (1) | CA2290475A1 (en) |
GB (1) | GB9710523D0 (en) |
WO (1) | WO1998052943A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030008880A1 (en) * | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
FR2888238B1 (en) * | 2005-07-07 | 2007-09-07 | Servier Lab | NOVEL 1H-INDOLE-PYRIDINECARBOXAMIDE AND 1H-INDOLE-PIPERIDINECARBOXAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARCEUMATIC COMPOSITIONS CONTAINING THEM |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
EA019819B1 (en) | 2008-05-23 | 2014-06-30 | ПАНМИРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | C crystalline polymorphic form of protein inhibitor activating 5-lipoxygenase, pharmaceutical composition based thereon and use in treatment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199700749T1 (en) * | 1995-02-02 | 1998-02-21 | Smithkline Beecham P.L.C. | Indole derivatives as 5-HT receptor antagonists. |
GB9612885D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-05-23 GB GBGB9710523.3A patent/GB9710523D0/en active Pending
-
1998
- 1998-05-13 WO PCT/EP1998/002992 patent/WO1998052943A1/en not_active Application Discontinuation
- 1998-05-13 CA CA002290475A patent/CA2290475A1/en not_active Abandoned
- 1998-05-13 EP EP98925626A patent/EP0984956A1/en not_active Withdrawn
- 1998-05-13 JP JP54996098A patent/JP2001526674A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1998052943A1 (en) | 1998-11-26 |
EP0984956A1 (en) | 2000-03-15 |
JP2001526674A (en) | 2001-12-18 |
CA2290475A1 (en) | 1998-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24412A (en) | Novel compounds | |
EG24177A (en) | Novel compounds | |
GB9701684D0 (en) | Novel compounds | |
GB9706255D0 (en) | Novel compounds | |
GB9707830D0 (en) | Novel compounds | |
GB9710523D0 (en) | Novel compounds | |
GB9703492D0 (en) | Novel compounds | |
GB9705619D0 (en) | Novel compounds | |
GB9708095D0 (en) | Novel compounds | |
GB9700694D0 (en) | Novel compounds | |
GB9700901D0 (en) | Novel compounds | |
GB9700902D0 (en) | Novel compounds | |
GB9701597D0 (en) | Novel compounds | |
GB9700688D0 (en) | Novel compounds | |
GB9703011D0 (en) | Novel compounds | |
GB9703333D0 (en) | Novel compounds | |
GB9703334D0 (en) | Novel compounds | |
GB9703402D0 (en) | Novel compounds | |
GB9703491D0 (en) | Novel compounds | |
GB9700687D0 (en) | Novel compounds | |
GB9703493D0 (en) | Novel compounds | |
GB9704461D0 (en) | Novel compounds | |
GB9704462D0 (en) | Novel compounds | |
GB9705385D0 (en) | Novel compounds | |
GB9708062D0 (en) | Novel compounds |